Serum levels of angiotensin-converting enzyme 2 in children with Kawasaki disease

• Published in: Clinical and experimental medicine Vol. 23; no. 4; pp. 1325 - 1330
• Main Authors: Gan, Yi, Feng, Yawei, Zhou, Xiaoqin, Li, Heng, Wang, Guirong, Aini, Maidina, Shu, Junhua, Tu, Danna
• Format: Journal Article
• Language: English
• Published: Cham Springer International Publishing 01.08.2023; Springer Nature B.V
• Subjects: ACE2; Angiotensin; Angiotensin-converting enzyme 2; Children; Enzyme-linked immunosorbent assay; Enzymes; Heart diseases; Hematology; Internal Medicine; Kawasaki disease; Medicine; Medicine & Public Health; Mucocutaneous lymph node syndrome; Oncology; Original; Original Article; Patients; Peptidyl-dipeptidase A; Rheumatic fever; Serum levels; Intravenous immunoglobulin treatment; Kawasaki disease; Mucocutaneous lymph node syndrome; Coronary artery damage; ACE2 levels
• ISSN: 1591-9528; 1591-8890; 1591-9528
• DOI: 10.1007/s10238-022-00933-x

Kawasaki disease (KD) has replaced rheumatic fever as the main cause of acquired heart disease in Japanese, American, and Chinese children. Polymorphisms in angiotensin-converting enzyme may be associated with susceptibility to KD, but the association of angiotensin-converting enzyme 2 (ACE2) with vascular endothelial injury in KD and the possibility for prognosis of vascular injury in KD by evaluating changes in serum ACE2 have not yet been assessed. Thus, this study aimed to investigate ACE2 levels in patients with KD to further explore the relationship between ACE2 and vascular injury in KD. Blood samples were collected from 49 children with KD before intravenous immunoglobulin treatment and 28 healthy children in the same period as the control group. Clinical data were collected from the patients and serum ACE2 levels of all participants were measured using an enzyme-linked immunosorbent assay. Serum ACE2 levels were significantly higher in the KD group than in the control group, and were negatively correlated with platelet levels in patients with KD. Serum ACE2 levels are related to the pathogenesis of KD and may be used as a potential serum marker for KD diagnosis.